CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 99 filers reported holding CUE BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is 9.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $396,000 | -22.4% | 35,000 | 0.0% | 0.16% | -34.5% |
| Q3 2021 | $510,000 | +25.0% | 35,000 | 0.0% | 0.24% | +39.2% |
| Q2 2021 | $408,000 | -4.4% | 35,000 | 0.0% | 0.17% | -41.2% |
| Q1 2021 | $427,000 | -77.3% | 35,000 | -76.7% | 0.29% | -61.8% |
| Q4 2020 | $1,877,000 | -16.9% | 150,000 | 0.0% | 0.76% | +37.4% |
| Q3 2020 | $2,258,000 | -52.1% | 150,000 | -22.1% | 0.55% | -38.6% |
| Q2 2020 | $4,718,000 | +58.3% | 192,505 | -8.3% | 0.90% | +144.4% |
| Q1 2020 | $2,980,000 | +10.4% | 210,000 | +23.5% | 0.37% | -71.6% |
| Q4 2019 | $2,700,000 | – | 170,000 | – | 1.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 829,042 | $9,376,000 | 5.61% |
| P.A.W. CAPITAL CORP | 120,000 | $1,357,000 | 1.24% |
| Nantahala Capital Management | 2,539,700 | $28,724,000 | 1.01% |
| Slate Path Capital LP | 1,483,619 | $16,780,000 | 0.88% |
| SANDERS MORRIS HARRIS LLC | 359,113 | $4,416,000 | 0.76% |
| APOGEM CAPITAL LLC | 62,295 | $705,000 | 0.46% |
| Robertson Stephens Wealth Management, LLC | 478,500 | $5,411,000 | 0.46% |
| Bleichroeder LP | 200,000 | $2,262,000 | 0.35% |
| ADVISORY RESEARCH INC | 257,225 | $2,909,000 | 0.23% |
| Granite Point Capital Management, L.P. | 110,000 | $1,244,000 | 0.21% |